Scalability Metrics and Effort Requirements for a Long-Acting Injectable Antiretroviral Treatment Program. [PDF]
Havens JP +7 more
europepmc +1 more source
Highlights on HIV Prevention and Antiretroviral Therapy from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 and Expectations from CROI 2026. [PDF]
İnan A +3 more
europepmc +1 more source
Staff Perspectives on Implementation of Long-Acting Injectable Preexposure Prophylaxis at a Low-Barrier Syringe Services Program in Philadelphia, PA. [PDF]
Plesons M +7 more
europepmc +1 more source
Health Worker Experiences and Perspectives on the Integration of Long-Acting Injectable Antiretroviral Therapy into a Safety-Net HIV Clinic in the Southeastern United States. [PDF]
Huffstetler HE +7 more
europepmc +1 more source
Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 Years. [PDF]
Calcagno A +17 more
europepmc +1 more source
Cost-effectiveness of leveraging long-acting injectable cabotegravir to expand PrEP coverage among MSM in two contrasting North American cities. [PDF]
Heitner JA +11 more
europepmc +1 more source
A Community Advisory Board's Role in Disseminating Tai Chi Prime in African American and Latinx Communities: A Pragmatic Application of the Consolidated Framework for Implementation Research. [PDF]
Salihu EY +7 more
europepmc +1 more source
Long-Acting Antiretroviral Therapy for Breastfeeding Women With HIV Experiencing Barriers to Adherence in Zimbabwe: Modeling Clinical Impact and Cost-effectiveness. [PDF]
Tewari SE +18 more
europepmc +1 more source

